-+ 0.00%
-+ 0.00%
-+ 0.00%

Clearmind Medicine Announces 1-For-8 Reverse Share Split, Effective October 5, 2026

Benzinga·09/30/2026 20:54:04
Listen to the news

learmind Medicine Inc. (the "Company") is announcing that it will effect a reverse share split of the Company’s common shares at the ratio of 1-for-8, such that each eight (8) common shares, no par value, shall be consolidated into one (1) common share, no par value. The first date when the Company’s ordinary shares will begin trading on the Nasdaq Capital Market after implementation of the reverse split will be Monday, October 5, 2026.